|
|
Home > Healthcare > Pharmaceutical > Drug Products
U.S. and European Markets for Psychotropic Pharmaceuticals
|
| Published Date:
November 1996
Published By:
Kalorama Information
Page Count:
216
Order Code:
R566-195
|
|
Now 50% off the original sale price of $3,250.
This report from Kalorama Information provides analysis of the dynamic U.S. market for existing and emerging psychotherapeutic drugs. Examines seven primary market segments, anti-anxiety agents, antidepressants, antimanic agents, antipsychotic medications, CNS stimulants, substance-related disorder treatments, and emerging drugs in development. Provides in-depth coverage of historical, current, and forecast market size for each of the categories. Profiles major competitors and emerging industry participants.
|
Similar Products
• Traditional Medicines in the BRIC (Brazil, Russia, India, China) Countries - Market Overview and Forecasts to 2014
Published Jul 2010 by Datamonitor
• Pipeline and Commercial Insight: Insomnia - Future of innovative orexin drug class in doubt
Published Jul 2010 by Datamonitor
• Pipeline and Commercial Insight: Allergic Rhinitis - Immunotherapy growth surpassed by generic erosion
Published Jul 2010 by Datamonitor
• Migraine Market Forecast
Published Jul 2010 by Datamonitor
• Pipeline and Commercial Insight: Migraine - Challenges ahead for first-in-class developments
Published Jul 2010 by Datamonitor
• U.S. Opioid Pain Management Market
Published Jul 2010 by Frost & Sullivan
• Prescription Drug Wholesaling in the US - Industry Risk Rating Report
Published Jul 2010 by IBISWorld
• Pharmaceuticals Industry Report
Published Jul 2010 by Plimsoll Publishing Ltd.
• Pharmaceuticals Manufacture
Published Jun 2010 by First Research, Inc.
• Snapshots Argentina Pharmaceuticals 2010
Published Jun 2010 by Snapdata International Group
|
|
|
|
0 items
Questions About This Report
E-mail a Colleague
Printable Page
Fax Your Order